Nanodrug tames leishmaniasis and other parasitic diseases

Bar-Ilan researcher working to commercialize her formula that protects against and treats diseases from trypanosomes transmitted by biting flies.

Prof. Shulamit Michaeli, vice president for research at Israel’s Bar-Ilan University, is working to commercialize a nanodrug to protect against and treat leishmaniasis and other diseases caused by trypanosomes transmitted by biting flies, such as sleeping sickness (African trypanosomiasis) and Chagas disease (American trypanosomiasis) prevalent in Latin America.

In collaboration with Prof. Jean-Paul (Moshe) Lellouche, chairman of Bar-Ilan’s chemistry department, Michaeli’s life-sciences lab in the Bar-Ilan Institute of Nanotechnology and Advanced Materials (BINA) developed a patented compound that kills the two types of Leishmania parasites found in Israel as well as the Leishmania that cause visceral leishmaniasis.

A combination of a polymer and a pharmaceutical ingredient bonded together by specially fabricated iron oxide nanoparticles, the drug takes only about 20 minutes to do its job in the lab culture.

from: ISRAEL21c  AUGUST 5, to the article